O’Melveny & Myers represented Nkarta, Inc. in the offering, and Shearman & Sterling represented the underwriters. Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural...
Nkarta’s $240 Million Common Stock Offering
Janux Therapeutics’ $296.5 Million Common Stock Offering
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
Prime Medicine’s $161.0 Million Common Stock Offering
Goodwin Procter advised Prime Medicine and Wilson Sonsini Goodrich & Rosati advised Prime Medicine on IP matters related to the transaction, while Davis Polk & Wardwell...
Kymera Therapeutics’ $316.2 Million Common Stock Offering
Goodwin Procter advised Kymera Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters. Kymera Therapeutics, Inc. (Nasdaq: KYMR) (“Kymera”) announced its...
CARGO Therapeutics’ $281.3 Million Initial Public Offering
Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised CARGO Therapeutics, Inc. on the offering, and Cooley advised the underwriters. CARGO Therapeutics, Inc. (CARGO) (Nasdaq:CRGX)...
Alpine Immune Sciences’ $150 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised Alpine Immune Sciences on the offering, and Latham & Watkins advised the underwriters. Alpine Immune Sciences, Inc. (Nasdaq: ALPN) announced the...
Klaviyo’s $576 Million Initial Public Offering
Goodwin Procter advised Klaviyo, and Sidley Austin advised the underwriters on the offering. Klaviyo, Inc. announced the pricing of its initial public offering of 19,200,000 shares of...
NuScale Power Corporation’s $150 Million ATM Offering
Nelson Mullins Riley & Scarborough LLP represented Cowen and Company, LLC, B. Riley Securities, Inc., and Canaccord Genuity LLC on the offering of NuScale Power Corporation....
Rocket Pharmaceuticals’ $175 Million Public Offering
K&L Gates advised Rocket, and Latham advised underwriters. Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) announced the pricing of an underwritten public offering of 7,812,500 shares of its common...
Natera’s $250 Million Follow-On Offering
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Natera, and Davis Polk & Wardwell advised the representatives of the several underwriters on the offering. Natera, Inc....
Dutch Bros’ $300 Million Class A Common Stock Offering
Cooley advised Dutch Bros, and Latham & Watkins advised the underwriters. Dutch Bros Inc. (NYSE: BROS; Dutch Bros) announced the pricing of an underwritten offering of...
Vicarious Surgical’s $45 Million Follow-On Offering
Mintz Levin advised Vicarious, and Shearman & Sterling advised the underwriters. Vicarious Surgical Inc. announced its follow-on offering of 45,000,000 shares of Class A common stock at...